Table 1.
Sample | Serotype/serogroup(s) |
|||||
---|---|---|---|---|---|---|
Lung aspirate | Nasopharyngeal |
|||||
1st | 2nd | 3rd | 4th | Predominant | ||
L1 | 14 | 14 | 19F | 19F | ||
L2 | 14 | 14 | 19A | 5 | 6 | 14* |
L3 | 6 | 6 | ||||
L4 | 1 | 1 | 9A/9V | 19F | 9A/9V | |
L5 | 1 | 1 | 6 | 23F | 19F | 1* |
L6 | 5 | 5 | ||||
L7 | 5 | 5 | 14 | 5* | ||
L8 | 14 | 14 | 9A/9V | 14* | ||
L9 | 1 | 1 | 6 | 19F | 19F | |
L10 | 1 | 1 | ||||
L11 | 1 | 1 | 15A/15F | 1* | ||
L12 | 14 | 14 | ||||
L13 | 5 | 5 | 6 | 5* | ||
L14 | 14 | 14 | 15A/15F | 14* | ||
L15 | 5 | 5 | ||||
L16 | 14 | |||||
L17 | 14 | 14 | 13 | 14* | ||
L18 | 1 | 14 | ||||
L19 | 14 | 6 | 19F | |||
L20 | 9A/9V | 9A/9V | 5 | 14 | 9A/9V* | |
L21 | 14 | 14 | ||||
L22 | 14 | 14 | ||||
L23 | 1 | 4 | ||||
L24 | 5 | 5 | 9A/9V | 5* | ||
L25 | 5 | 5 | ||||
L26 | 1 | 17 | ||||
L27 | ||||||
L28 | 5 | 5 | ||||
L29 | NEGATIVE | 14 | ||||
L30 | NEGATIVE | 9N/9L | ||||
L31 | NEGATIVE | 6 | 14 |
Lung aspirates L29 to L31 were S. pneumoniae negative and served as controls. Serotypes in nasopharyngeal aspirates concurrent with lung aspirates are shown in bold.
, predominant serotype in NPA also detected in the lung aspirate.